When dealing with breast cancer metastases, primary breast carcinoma with unusual morphology, or triple-negative breast cancers, TRPS1 is often used in conjunction with other IHC markers to increase the diagnostic confidence. This evidence concerns the gene TRPS1 and triple-negative breast carcinoma.